Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. clinical response
Show results for
Products
Services

Companies

News
Articles
Videos

Refine by
Locations

  • USA
  • Europe
  • Asia & Middle East
  • Australasia
  • North America
Brands

  • txinno bioscience
  • ardigen
  • byfavo
  • creative peptides
  • dimed
View all brands
Applications

  • Versius - Surgical Robotic Systems for Surgeons
  • Versius - Surgical Robotic Systems for Surgical Teams
  • Versius - Surgical Robotic Systems for Hospitals
  • Versius - Surgical Robotic Systems for Commitment to Research
  • Microbiome Therapeutics for Patients and Physicians

Clinical Response Equipment & Supplies

28 equipment items found

Central Monitor System

Central Monitor System

Manufactured by:Shenzhen Colinn Medical Co., Ltd   based inShenzhen, CHINA
Central Monitoring System is widely used in various department in hospital to centrally collect up to 128 patients’ physiological data, review patient vital acute care data and give alarms to hospital staff for fast clinical response. Colinn Magnolia Link provides: A central monitoring system for clinical department in dedicated network, ...
CONTACT SUPPLIER

NuBiyota - Microbiome Therapeutics

NuBiyota - Microbiome Therapeutics

Manufactured by:NuBiyota   based inNew York, NEW YORK (USA)
Microbiome therapeutics are a novel approach to restoring equilibrium within the microbiome, which in turn can evoke the required clinical response to suppress flares or promote remission. Multiple studies have shown the efficacy of fecal microbiota transplantation (FMT) to restore gut microbiota diversity, with positive outcomes for varied medical ...
CONTACT SUPPLIER

Sumitomo - Immunotherapeutic Cancer Vaccines

Sumitomo - Immunotherapeutic Cancer Vaccines

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be ...
CONTACT SUPPLIER

Therawis - Model therascreen PITX2 - Personalized Medicine

Therawis - Model therascreen PITX2 - Personalized Medicine

Manufactured by:Therawis   based inMunich, GERMANY
Prognostic biomarkers provide information on the risk of disease recurrence whereby predictive ones will inform the physician of the potential clinical response of the patient to a given cancer therapy. “In personalized medicine biomarkers are used to predict prognosis (prognostic biomarkers) and treatment success (predictive ...
CONTACT SUPPLIER

Model QN-247 - Aptamer-Based investigational Drug

Model QN-247 - Aptamer-Based investigational Drug

Manufactured by:Qualigen Therapeutics, Inc.   based inCarlsbad, CALIFORNIA (USA)
A key component of this drug candidate, the QN-165 aptamer, has been tested in over 100 cancer patients and is well tolerated with no evidence of severe side effects; with at least 7 patients having long-lasting clinical responses in which their cancers disappeared or shrank substantially. QN-247 binds the aptamer QN-165 to a gold nanoparticle, which gives it ...
CONTACT SUPPLIER

Evogam - Human Normal Immunoglobulin

Evogam - Human Normal Immunoglobulin

Manufactured by:CSL Behring   based inKing of Prussia, PENNSYLVANIA (USA)
Evogam is a sterile preservative-free solution containing 16 g/100 mL of total human plasma protein of which at least 98% is immunoglobulin G (IgG). At least 85% consists of monomers and dimers (typically >90%) ...
CONTACT SUPPLIER

Creative Peptides - Model 128517-07-7 - Romidepsin

Creative Peptides - Model 128517-07-7 - Romidepsin

Manufactured by:Creative Peptides   based inNew York, NEW YORK (USA)
Romidepsin is a selective inhibitor of histone deacetylase, approved in the US in 2009 for the treatment of cutaneous T-cell lymphoma (CTCL) or/and peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior systemic therapy. These indications are based on response rate. Clinical benefit such as improvement in overall survival has not been ...
CONTACT SUPPLIER

VERIGENE - Model II - Sample-to-Answer Molecular System

VERIGENE - Model II - Sample-to-Answer Molecular System

by:Diasorin   based inSALUGGIA, ITALY
The VERIGENE® II System is a sample-to-answer molecular diagnostic platform capable of performing both targeted and multiplex testing on a single sample. The system is fully-integrated and performs extraction, amplification, hybridization, and detection—all in one cartridge. Its proprietary Flex® Software enables users to test and pay only for the targets ordered by the clinician, ...
CONTACT SUPPLIER

Txinno Bioscience - Model ULK1 - Inhibitor

Txinno Bioscience - Model ULK1 - Inhibitor

Manufactured by:TxinnoBioscience Inc.   based inYongin-si, SOUTH KOREA
RAS GTPase family has 3 members encoding KRAS, HRAS and NRAS proteins which are involved in controlling normal growth signal. RAS GTPases are also well-known oncogenes that drive tumorigenesis when mutation is ...
CONTACT SUPPLIER

Seres - Model SER-109 C. Difficile - First-In-Class Investigational Microbiome Therapeutic

Seres - Model SER-109 C. Difficile - First-In-Class Investigational Microbiome Therapeutic

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-109 is a first-in-class investigational microbiome therapeutic administered orally following antibiotics to reduce recurrence of C. difficile infection (CDI) in patients with recurrent ...
CONTACT SUPPLIER

Dorian Therapeutics - Senoblocker Technology

Dorian Therapeutics - Senoblocker Technology

by:Dorian Therapeutics   based inSan Carlos, CALIFORNIA (USA)
During aging, there is a decrease in the activity of stem cells, and therefore a reduced regenerative capacity. Additionally, senescent cells accumulate in the body and poison entire tissues. Dorian’s Senoblockers act on epigenetic regulators to reverse both processes, reactivating programs of youthfulness and regeneration. ...
CONTACT SUPPLIER

Mediplus - Model Capnomask - Capnography Mask

Mediplus - Model Capnomask - Capnography Mask

Manufactured by:Mediplus Ltd.   based inHigh Wycombe, UNITED KINGDOM
The high-performance Capnomask™, a dedicated Capnography mask, offers a wide range of benefits ...
CONTACT SUPPLIER

Txinno Bioscience - Model ENPP1 - Emopamil-Binding Protein (EBP) Inhibitor

Txinno Bioscience - Model ENPP1 - Emopamil-Binding Protein (EBP) Inhibitor

Manufactured by:TxinnoBioscience Inc.   based inYongin-si, SOUTH KOREA
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), is a type II transmembrane protein with nucleotide pyrophosphatase and phosphodiesterase enzymatic activities. Recently, ENPP1 has been found to play an important role in regulating STING pathway. By hydrolyzing cGAMP (natural ligand of STING) into AMP and GMP, ENPP1 negatively regulates STING-mediated type I interferon production and ...
CONTACT SUPPLIER

Immunoscore - For Rectal Cancer

Immunoscore - For Rectal Cancer

Manufactured by:Veracyte   based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
CONTACT SUPPLIER

Upifitamab Rilsodotin (UpRi)

Upifitamab Rilsodotin (UpRi)

Manufactured by:Mersana Therapeutics   based inCambridge, MASSACHUSETTS (USA)
UpRi, a first-in-class ADC targeting the sodium-dependent phosphate transport protein NaPi2b, utilizes the Dolaflexin platform to deliver about 10 DolaLock payload molecules per antibody. The NaPi2b antigen is broadly expressed in ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma. UpRi is being studied in UPLIFT, a single-arm registration strategy, in patients with ...
CONTACT SUPPLIER

Model ABX464 - Ulcerative Colitis

Model ABX464 - Ulcerative Colitis

by:Abivax   based inParis, FRANCE
ABX464 is an oral, first-in-class, small molecule that has demonstrated safety and profound anti-inflammatory activity in preclinical trials and in Phase 2a and Phase 2b induction trials to treat ulcerative colitis (UC). Patients who completed the induction studies had the option to roll over into the respective open-label extension ...
CONTACT SUPPLIER

Immunotherapy for the Treatment of Kidney Cancer and Targets Stage 4 Renal Cell Carcinoma

Immunotherapy for the Treatment of Kidney Cancer and Targets Stage 4 Renal Cell Carcinoma

Manufactured by:TVAX Biomedical, Inc.   based inOlathe, KANSAS (USA)
TVAX®’s second candidate (TVI-Kidney-1) is being evaluated for the treatment of kidney cancer and targets stage 4 renal cell ...
CONTACT SUPPLIER

Finafloxacin for Complicated Urinary Tract Infections (cUTI)

Finafloxacin for Complicated Urinary Tract Infections (cUTI)

Manufactured by:MerLion Pharmaceuticals GmbH   based inBerlin, GERMANY
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its unique properties in activity, safety and flexible dosing regimen options, clearly distinguish finafloxacin from other, existing therapies, offering ...
CONTACT SUPPLIER

Dimed - Spider Vein Removal Machine

Dimed - Spider Vein Removal Machine

Manufactured by:Wuhan Dimed Laser Technology Co., Ltd   based inWuhan, CHINA
Telangiectasias, commonly known as Spider veins, are usually tiny dilated blood vessels beneath the skin surface and calibrating between 0.5 & 1 millimeter in their dimension. They might take place wherever on the body, nevertheless are normally observed around the nasal area, cheeks & chin. They may also appear on the lower limbs exclusively on the top of the legs, usually just below the ...
CONTACT SUPPLIER

Ardigen - Cancer Vaccines

Ardigen - Cancer Vaccines

Manufactured by:Ardigen   based inKraków, POLAND
Quick solution for effective immune responses in clinical trials; We have created an Artificial Intelligence platform dedicated to being a part of the therapeutic cancer vaccine development. The ArdImmune Vax platform uses sequencing data to generate and prioritize antigen targets for cancer vaccines and T-cell ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT